Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-01-25
2011-01-25
Kosack, Joseph R (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C549S354000
Reexamination Certificate
active
07875729
ABSTRACT:
Asenapine and related trans-isomer bicyclic compounds can be obtained by reducing a compound of formula (C) to preferentially form a trans-isomer compound of formula (D), followed by subsequent ring closure to form a compound of formula (B) such as asenapine.
REFERENCES:
patent: 4145434 (1979-03-01), van der Burg
patent: 1 710 241 (2006-10-01), None
patent: WO 95/23600 (1995-09-01), None
patent: WO 99/32108 (1999-07-01), None
Th. de Boer et al., “Antipsychotic Dopamine D2 Receptor Antagonist 5-HT2 Receptor Antagonist” Drugs of the Future 1993, 18(12): 1117-1123.
C. W. Funke et al., “Physico-chemical Properties and Stability of trans-5-Chloro-2-methyl-2,3,3a,12b-tetra . . . ” Arzneim-Forsch/Drug Res., 40(1) Nr. 5 (1990) pp. 536-539.
Firet Judith
Keltjens Rolf
Zhu Jie
Kosack Joseph R
Muncy Geissler Olds & Lowe, PLLC
Synthon BV
LandOfFree
Process for making asenapine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for making asenapine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for making asenapine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2644603